The Han Lab In the News

  • – BMIR Connection Newsletter

    QSU Investigator Summer Han Collaborates with Clinicians to Attack Second Primary Lung Cancer

    As a primary investigator running her own lab, Dr. Han relies on the multidisciplinary strengths of biostatisticians, epidemiologists, and medical doctors on her team as she pursues studies with practical ramifications. As an example, Han had developed a mathematical model that she wanted to convert into a web-based risk assessment tool to aid clinical decision making for lung cancer patients and survivors. Results to date led to the publication of Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer in the July 13, 2021 issue of the Journal of the National Cancer Institute.

  • – MedPage

    LDCT Screening Linked to Lower Risk of Brain Mets in Lung Cancer

    Patients with primary lung cancer detected with low-dose computed tomography (LDCT) screening have a lower risk of developing brain metastases than patients whose cancer was detected through other methods, researchers found.

  • – Docwire News

    Patients with Primary Lung Cancers Detected by LDCT at Reduced Risk of Brain Metasases - Docwire News

    A new study shows that patients with primary lung cancer detected using low-dose computed tomography (LDCT) screening have a lower risk of the cancer spreading to the brain, of developing brain metastases after diagnosis, according to a study published in the Journal of Thoracic Oncology.

  • – News Medical Life Sciences

    Lung cancer detected by LDCT screening linked to lower brain metastases risk

    Patients with primary lung cancer detected using low-dose computed tomography screening are at reduced risk of developing brain metastases after diagnosis, according to a study published in the Journal of Thoracic Oncology.

  • – Diagnostic Imaging

    Lung Cancer Detection with LDCT Linked to Lower Brain Metastasis Risk

    Patients who have their disease detected with low-dose CT have a half-fold risk of brain metastasis than patients screened with other methods. Add a lower risk of brain metastasis to the ever-growing list of benefits associated with low-dose CT (LDCT) lung cancer screening. According to a study published June 3 in the Journal of Thoracic Oncology, patients who have their lung cancer detected with LDCT have half the risk of a subsequent brain metastasis than do patients whose disease is diagnosed via alternative methods.